Carvedilol Tablet, Film Coated
Product Images NDC 51655-034

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 51655-034). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 034 25)

Carvedilol 3.125 mg film-coated tablets label showing 60 tablets in the package, for oral use. The label includes storage instructions, dosage note, and manufacturer details: Northwind Pharmaceuticals, repackaged by Northwind Health Company, LLC. The NDC code is 51655-034-25.*

FDA Label Image

Structured Formula For Carvedilol (B1fa8af3 9789 45d2 8b77 A53935c52b49 01)

Chemical structure of Carvedilol showing its molecular arrangement with connected rings and side chains, including a methoxyphenyl group and a hydroxyethylamine moiety.*

FDA Label Image

Carvedilol Tablets (B1fa8af3 9789 45d2 8b77 A53935c52b49 02)

A line graph showing percent mortality over 21 months comparing Carvedilol and placebo. The Y-axis represents % mortality, and the X-axis shows months. The Carvedilol group consistently shows lower mortality than placebo, with a p-value of 0.0014 indicated on the graph.*

FDA Label Image

Carvedilol Tablets (B1fa8af3 9789 45d2 8b77 A53935c52b49 03)

A forest plot chart depicting hazard ratios with confidence intervals for various patient subgroups. The subgroups include demographics (men, women), age categories (<65, ≥65), race (non-black, black), health conditions (diabetic, non-diabetic, ischemic, nonischemic), heart rate categories (≥70, <70), systolic blood pressure (SBP ≥120 mm Hg, SBP <120 mm Hg), and spironolactone use. The chart visually compares these groups' hazard ratios around the value of 1.0.*

FDA Label Image

Structured Formula For Carvedilol (B1fa8af3 9789 45d2 8b77 A53935c52b49 04)

A line graph illustrating mortality percentage over time in months for two groups: Carvedilol and Placebo. The y-axis represents percentage mortality from 0 to 30%, and the x-axis represents time from 0 to 24 months. The Carvedilol group shows consistently lower mortality compared to the Placebo group, with a statistical significance indicated by P = 0.03.*

FDA Label Image

Structured Formula For Carvedilol (B1fa8af3 9789 45d2 8b77 A53935c52b49 05)

A forest plot displaying hazard ratios for various patient subgroups including age, gender, timing post-myocardial infarction, prior use of IV or oral beta blockers, Killip class, thrombolytic treatment, PTCA for MI, history of congestive heart failure, angina, hypertension, diabetes, heart rate, and systolic blood pressure. The plot visually compares these subgroups with hazard ratios centered around 1.0, indicating relative risk assessments.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.